Semaglutide is gaining traction as a novel treatment for insulin resistance. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist functions through stimulating the pancreas to secrete more insulin and https://allenecgl770761.luwebs.com/36442750/grasping-semaglutide-a-comprehensive-guide